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Objectives: Age-related hearing impairment, or presbycusis, is the most common communication 
disorder and neurodegenerative disease in the elderly. Its prevalence is expected to increase, 
due to the trend of growth of the elderly population. The current diagnostic test for detection of 
presbycusis is implemented after there has been a change in hearing sensitivity. Identification of 
a pre-diagnostic biomarker would raise the possibility of preserving hearing sensitivity before 
damage occurs. Mitochondrial dysfunction, including the production of reactive oxygen species 
and induction of expression of apoptotic genes, participates in the progression of presbycusis. 
Mitochondrial DNA sequence variation has a critical role in presbycusis. However, the nature 
of the relationship between mitochondrial DNA copy number, an important biomarker in many 
other diseases, and presbycusis is undetermined.
Methods: Fifty-four subjects with presbycusis and 29 healthy controls were selected after ear, 
nose, throat examination and pure-tone audiometry. DNA was extracted from peripheral blood 
samples. The copy number of mitochondrial DNA relative to the nuclear genome was measured 
by quantitative real-time polymerase chain reaction.
Results: Subjects with presbycusis had a lower median mitochondrial DNA copy number than 
healthy subjects and the difference was statistically significant (P=0.007). Mitochondrial DNA 
copy number was also significantly associated with degree of hearing impairment (P=0.025) 
and audiogram configuration (P=0.022).
Conclusion: The findings of this study suggest that lower mitochondrial DNA copy number 
is responsible for presbycusis through alteration of mitochondrial function. Moreover, the sig-
nificant association of mitochondrial DNA copy number in peripheral blood samples with the 
degree of hearing impairment and audiogram configuration has potential for use as a standard 
test for presbycusis, providing the possibility of the development of an easy-to-use biomarker 
for the early detection of this condition.
Keywords: age-related hearing impairment, presbycusis, biomarker, mtDNA
Introduction
Presbycusis, or age-related hearing impairment, manifests as symmetric, bilateral, 
sensorineural hearing impairment, occurring slowly over a lifetime.1 It is a major 
reason for hearing impairment in adults. Recently, Homans et al conducted a large 
cohort study that showed that 33% of men and 29% of women aged .65 years suffer 
from presbycusis.2 Presbycusis affects communication skills, gradually leading to 
isolation, depression, and frustration. Thus, the condition greatly impacts the quality 
of human life and general health.1,3 Panza et al demonstrated that presbycusis is a 
risk factor for dementia and cognitive decline.4 There is, as yet, no treatment for 
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presbycusis, which develops over many years and people 
are usually identified after their hearing sensitivity change.5 
Various research groups are seeking a biomarker for this 
common impairment;6–9 development of a sensitive and 
specific biomarker for detection and prediction of presby-
cusis could reduce the impact of the condition on the health 
of society in the future. 
Mitochondria are intracellular bodies, and their impair-
ment contributes to presbycusis.10 These are the only cellular 
organelles that contain their own genomes, known as mtDNA. 
According to the mitochondrial theory of aging proposed by 
Harman,11 accumulation of reactive oxygen species (ROS) 
produced by mitochondria causes damage to intracellular 
macromolecules, particularly mtDNA. A lack of introns and 
protective histones make mtDNA more susceptible to ROS 
and other types of damage, which could lead to sequence 
mutations or copy number alterations.12 Variation of both 
quality (mutations)13,14 and quantity (copy number)15 of 
mtDNA has been associated with many human diseases, 
including neurodegenerative diseases,16 metabolic diseases, 
and various types of cancer,17 as well as in the process of 
aging.18 Therefore, the application of mtDNA alteration 
as a biomarker in aging, age-related diseases, cancers, 
metabolic diseases, and even forensic science is currently 
being investigated.19,20
In recent years, studies have identified some chromo-
somal loci and genes associated with presbycusis.3,21,22 
A comparison of the mtDNA from temporal bones of 
presbycusis patients with that of healthy controls revealed 
a significant relationship between large-scale deletions in 
mtDNA and presbycusis.23–25 In addition to large deletions, 
there are reports of single nucleotide changes to mitochon-
drial genomes associated with presbycusis.26 To determine 
the role of mtDNA copy number in the development of 
presbycusis and investigate the possibility of using mtDNA 
copy number as a biomarker for this impairment, we com-
pared the mtDNA copy number in subjects with presbycusis 
and healthy controls by quantitative real-time polymerase 
chain reaction (PCR).
Materials and methods
All 50- to 90-year-old volunteers participating in the molecu-
lar investigation of presbycusis at the ENT and Head and 
Neck Research Center and Department, Iran University of 
Medical Sciences completed a questionnaire, based on that 
developed by the European presbycusis consortium, which 
included questions to determine a full medical history and 
details of exposure to environmental factors that affect 
hearing.21,27 Participants with confounding factors (any known 
reason for hearing loss, exposure to ototoxic drugs, and other 
pathologies correlated with hearing loss, such as cardiovas-
cular disorder, liver cirrhosis, renal failure, and head and 
neck tumor), neurodegenerative diseases, and cancers were 
excluded. Otoscopic examination and pure-tone audiometry 
were performed on all volunteers. Air conduction was mea-
sured at octave frequencies of 250–8,000 Hz and bone con-
duction at 250–4,000 Hz using an Amplaid 319 audiometer 
(Milan, Italy). Calibration was performed according to the 
American National Standards Institute (ANSI, 2004a). Sub-
jects with any kind of middle ear pathology affecting hearing 
sensitivity, conductive hearing loss (mean air-bone differ-
ences at 500, 1,000, and 2,000 Hz of $15 dB), and extensive 
noise exposure (self-reported) were excluded.
Presbycusis patients (n=54) with symmetric, bilateral 
hearing impairment with the pure-tone average of mean 
frequencies 1, 2, 4, and 8 kHz of $30 dB HL were selected. 
Healthy subjects (n=29) with normal ear examination and 
the pure-tone average of mean frequencies #25 dB HL 
were selected. The mean age of patients was 66.87±8.9 years 
and that of healthy subjects was 63±5.3 years. The gender 
ratio was 54.2% male and 45.8% female, and there were 
no statistically significant differences in age and gender 
between presbycusis and healthy subjects (P.0.05). This 
study was approved by the Ethics Committee of Iran 
University of Medical Sciences, and all subjects provided 
signed informed consent.
Genomic DNA was extracted from peripheral blood sam-
ples using the QIAamp DNA Mini Kit (Cat No 51304; Qiagen, 
Hilden, Germany) according to the manufacturer’s protocol. 
Relative mtDNA copy number was determined 
through simultaneous assessment of the nuclear gene, 
TMIE (NC_000003.12), and the mitochondrial gene, MT-
RNR1 (NC_012920.1), using quantitative PCR (qPCR). 
Primers were as follows: MT-RNR1-F, 5′-AGTAG 
AGTGCTTAGTTGAGC-3 ′ ;  MT-RNR1-R, 5 ′-AG 
TACACTTCCATGTTACG-3′; TMIEF, 5′-CCATTC 
CTTGGGTCTCTGAA-3′; and TMIER, 5′-AGCAGA 
GGAACAGGGTGAC-3′. qPCR was performed using a 
Rotor-gene 6000 instrument (Corbett Life Science, Sydney, 
Australia) and QuantiFast SYBR Green PCR master mix 
(Cat No 204054, Qiagen). All reactions were performed in 
duplicate with total reaction volumes of 10 μL, containing 
5 μL of 1X Quanti Fast SYBR Green PCR master mix, 
0.12 μL of each primer (10 pmol), 0.7 μL of DNA, and 4 μL 
of RNase-free water. After initial heating for 1 min at 95°C 
as an activation step, 40 cycles of denaturation at 95°C for 
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10 s, followed by annealing and extension at 60°C for 45 s, 
were performed. 
The threshold cycle (Ct) of each sample was determined 
for MT-RNR1 and TMIE. Relative mtDNA copy number 
was determined using the following equation: 2-ΔCt (Δ Ct = 
Ct
MT-RNR1
 – Ct
TMIE
).
Standard curves were prepared for both nuclear and 
mitochondrial PCR. R2 correlation for each standard curve 
was $0.99. Melting curve analysis of qPCR and running 
of PCR products on agarose gels (1.5%) were performed to 
confirm amplification of a specific product without primer 
dimmer or unwanted PCR product.
Statistical analyses were performed using SPSS 22 for 
Windows (IBM, Chicago, IL, USA). All numerical variables 
were checked for normal distribution using the one-sample 
Kolmogorov–Smirnov test. The association between the 
mtDNA copy number in presbycusis and healthy subjects 
was evaluated using the Mann–Whitney U-test. The associa-
tions between mtDNA copy number and degree of hearing 
impairment and audiogram configuration were evaluated 
using Kruskal–Wallis H-test. Statistical significance was 
defined as P,0.05.
Results
The degree of hearing impairment of subjects with pres-
bycusis was classified into five categories according to the 
American Speech–Language–Hearing Association: mild, 
moderate, moderately severe, severe, and profound.28 Patients 
in this study suffered from mild, moderate, and moderately 
severe hearing impairment (Figure 1A). 
Based on audiogram configuration described previously, 
patients were divided into five groups: flat, high-frequency 
gently sloping (HFGS), high-frequency steeply sloping 
(HFSS), low-frequency ascending, and mid-frequency 
U-shape.29 Presbycusis subjects in this study exhibited flat, 
HFGS, and HFSS shapes (Figure 1B). 
The mean audiograms of presbycusis patients and healthy 
subjects are presented in Figure 2.
The mitochondrial copy number of study participants was 
evaluated by measuring the proportion of mtDNA relative to 
nuclear DNA using the level of MT-RNR1 as an evaluation 
index of the mitochondrial genome and that of TMIE for 
nuclear DNA. Median mtDNA copy number for subjects 
with presbycusis was 0.76, whereas that of healthy subjects 
was 1.45, indicating that the mitochondrial copy number of 
subjects with presbycusis was almost halved compared with 
the healthy controls (Figure 3). The difference in mtDNA 
copy number between the two groups was statistically sig-
nificant (P=0.007). 
A Kruskal–Wallis H-test showed that there was a statisti-
cally significant difference in mtDNA copy number between 
the different hearing degrees, χ2(3) =9.33, P=0.025, with a 
mean rank mtDNA copy number of 50.79 for normal, 29.72 for 
mild, 38.20 for moderate, and 44.64 for moderately severe.
A Kruskal–Wallis H-test showed that there was a statisti-
cally significant difference in mtDNA copy number between 
the different audiogram configurations, χ2(2) =7.62, P=0.022, 
with a mean rank mtDNA copy number of 51.23 for flat 
shape, 32.96 for HFGS shape, and 37.68 for HFSS shape.
Discussion
Presbycusis is categorized as a complex or multifactorial 
disorder.30,31 Factors affecting its development include 
genetic background, environmental factors, ototoxic drugs, 
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Figure 1 (A) Classification of presbycusis patients by degree of hearing impairment (n=54). (B) Classification of patients by shape of audiogram.
Abbreviations: hFgs, high-frequency gently sloping; hFss, high-frequency steeply sloping.
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medical conditions, and hormonal factors.32–34 Presbycusis 
occurs as a result of degeneration of both the inner ear 
structure and the central auditory system of the brain.35–37 
Mitochondria play a key role in cellular damage and death in 
the aging process of hearing.38,39 Mitochondrial dysfunction is 
related to the development of certain neurodegenerative, age-
related diseases, and cancer.14,40 Mutations in the MT-RNR1 
and MT-TF genes can cause hearing loss.26,41 Investigation 
of the temporal bone of presbycusis patients showed an 
increase in deletions and point mutations in mtDNA. Bai et al 
detected a 4,977 bp deletion, known as the common dele-
tion, in the mtDNA of human cochlear tissue of presbycusis 
patients.23,24 Markaryan demonstrated that the expression of 
the MT-CO3 gene is decreased in spiral ganglion cells from 
individuals with presbycusis, suggesting that deficits in the 
electron transport chain of spiral ganglion cells contribute 
to presbycusis.25
The results of this study indicate a statistically significant 
decrease in mtDNA copy number in presbycusis subjects. 
Our study is the first to investigate the relationship between 
mtDNA copy number and presbycusis. Previously, Santos 
et al proposed a decrease in mtDNA copy number as an 
important marker for oocyte quality, having shown that such 
a decrease is due to insufficient mitochondrial biogenesis 
or cytoplasmic maturation, causing fertilization failure.42 
Studies of the relationship between neurodegenerative 
disease and mtDNA content have produced similar results to 
those of our study. Podlesniy et al suggested low content of 
mtDNA in cerebrospinal fluid as a novel biomarker for the 
early detection of preclinical Alzheimer’s disease.43 Petersen 
et al demonstrated reduced mtDNA copy number in blood 
leukocytes from patients with Huntington’s disease.16
Our results are consistent with previous studies dem-
onstrating that presbycusis is commonly a high-frequency 
hearing impairment, as HFSS was the most common configu-
ration in patients in this study (70.9%), followed by HFGS 
(23.64%) (Figure 1B).1,44
According to previous studies, a decrease in the number 
of mitochondrial genomes can cause impaired or reduced 
mitochondrial activity. A study using HeLa cells indicated 
that depletion of the mitochondrial genome by decreasing 
catalase expression enhances oxidative damage to nuclear 
DNA and influences nuclear genome stability.45 Oxidative 
stress is associated with excessive ROS production in the 
mitochondrial matrix; ROS increases death of cellular 
structures of the cochlear, leading to an increase in muta-
tions in the mitochondrial genome.40 In transgenic mice, 
accumulation of mtDNA mutations by mitochondrial dys-
function influences energy metabolism. The consequent 
reduction in energy production induces apoptosis, leading to 
a loss of critical cochlear cells and resulting in age-related 
hearing impairment.46
The results of this study, together with those of previ-
ous reports demonstrating the relationship between mtDNA 
sequence variation and presbycusis,23,26,47 highlight the role of 
mtDNA in presbycusis progression. A significant reduction 
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Figure 2 Mean audiograms of patients with presbycusis and healthy subjects. error 
bars represent sDs.
Abbreviation: sD, standard deviation.
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Figure 3 Distribution of peripheral blood mtDna copy number in iranian patients 
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in the number of mitochondrial genomes in presbycusis 
subjects, due to mitochondrial dysfunction, may be one of 
the molecular mechanisms involved in the development of 
this impairment. In addition, quantification of mtDNA in 
peripheral blood samples may constitute an easily assessed 
biomarker of presbycusis, since the high-sensitivity qPCR-
based assay can detect even minute variations in mtDNA copy 
number. This blood biomarker could easily be incorporated 
into regular physical examinations as it employs a simple 
and cheap screening method. Moreover, the results of this 
study demonstrate that mtDNA copy number is statistically 
significantly associated with the degree of hearing (P=0.025) 
and audiogram configuration (P=0.022). Clearly, these results 
require further confirmation in a larger study population to 
determine whether the method is appropriate for clinical 
application. In addition, more research is required to under-
stand the relationship between the decrease in mtDNA copy 
number and the onset of presbycusis.
Age-related hearing impairment is the most common 
sensory disease in the elderly population.10 With the growth of 
the aging population, the prevalence of age-related disorders 
such as presbycusis is increasing.1 The World Health Organiza-
tion estimates that in 2025, more than 500 million individuals 
will suffer from presbycusis.48 Presbycusis begins slowly, with-
out clinical manifestation. Further human studies are required 
to elucidate methods for early diagnosis and prevention.
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